China Investigates 16 Guangdong Hospital Execs On Corruption Allegations
This article was originally published in PharmAsia News
Executive Summary
The prosecutor of China's Guangdong Province said nine of the heads of Shenzhen's 13 hospitals are under investigation for possible graft charges related to bribery involving purchases of medical devices, drugs and other equipment.